We are developing a potent and highly selective, orally bioavailable drug candidate for pain management as an effective alternative to opioids, encompassing chronic and neuro-pathic pain indications, two areas with high medical unmet need. We are also developing a pipeline of orthologous candidates which have unique profiles and activities required to selectively engage their biological pathway for the treatment of various pain conditions and mood disorders.
We are developing a highly selective, orally bioavailable neuro-inflammatory drug candidates, for the treatment of CNS conditions with high unmet medical need where neuro-inflammation is a major component. Our pipeline includes a wide range of neuro-inflammation candidates targeting specific cell types and various pathways, with unique profiles that combine the activity required to engage biological pathways involved in neuro-inflammation while being selectively transported by MFSD2A transporter into brain and to specific brain cell types involved in neuro-inflammation.
We are developing potent and highly brain bioavailable neuro-oncology drug candidates for the treatment of several types of brain tumors.